<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01351324</url>
  </required_header>
  <id_info>
    <org_study_id>CMW-BB/E021816/1</org_study_id>
    <nct_id>NCT01351324</nct_id>
  </id_info>
  <brief_title>A Study of Different Types of Fatty Acid on Risk Factors for Heart Disease</brief_title>
  <acronym>eFAIRE</acronym>
  <official_title>Acute Elevation of Non-esterified Fatty Acids on Endothelial Function and Insulin Sensitivity: A Comparison of Saturated and Long Chain n-3 Polyunsaturated Fatty Acids During the Postprandial Phase</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Reading</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Biotechnology and Biological Sciences Research Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Unilever R&amp;D</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Foundation for Research Science and Technology (New Zealand)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Reading</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Experimental elevation of non-esterified fatty acids (NEFA) impairs endothelial function and
      insulin sensitivity but the impact of NEFA composition is unknown.

      The objective was to test the effect of acute elevation of NEFA enriched with either
      saturated fatty acids (SFA) or SFA with long-chain n-3 polyunsaturated fatty acids (LC n-3
      PUFA) on postprandial vascular function measured via flow-mediated dilatation (FMD), laser
      Doppler iontophoresis (LDI) and digital volume pulse (DVP), followed by a
      hyperinsulinaemic-euglycaemic clamp as a measure of whole body insulin sensitivity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To investigate potential diet-gene interactions, potential subjects (n=370) were
      prospectively genotyped for the eNOS Glu298Asp polymorphism, of which 35 were Asp298 and 150
      were Glu298 homozygotes. Three subjects in the Asp298 group were unable to participate, two
      were unsuitable according to selection criteria and one subject subsequently withdrew from
      the study. Subjects homozygous for Asp298 (n=29) and Glu298 (n=30) were therefore selected,
      balanced for gender, age and BMI.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">May 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Flow-mediated dilatation</measure>
    <time_frame>Change from baseline to 240 min</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Flow-mediated dilatation</measure>
    <time_frame>Change from 240 min to 390 min</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Digital volume pulse</measure>
    <time_frame>Change from baseline to 240 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Laser Doppler iontophoresis</measure>
    <time_frame>Change from baseline to 240 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin sensitivity</measure>
    <time_frame>390 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NEFA composition</measure>
    <time_frame>Change from baseline to 240 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Circulating endothelial function markers</measure>
    <time_frame>Change from baseline to 240 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Digital volume pulse</measure>
    <time_frame>Change from 240 min to 390 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Laser Doppler iontophoresis</measure>
    <time_frame>Change from 240 min to 390 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Circulating endothelial markers</measure>
    <time_frame>Change from 240 min to 390 min</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">59</enrollment>
  <condition>Cardiovascular Risk Factors</condition>
  <arm_group>
    <arm_group_label>SFA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral dose of palmitic acid (SFA) given as a chocolate-flavoured drink every 30 min (0-390 min) with a continuous infusion of heparin (60-390 min).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SFA + LC n-3 PUFA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral dose of palmitic acid and DHA-rich fish oil (SFA + LC n-3 PUFA) given as a chocolate-flavoured drink every 30 min (0-390 min) together with a continuous infusion of heparin (60-390 min).</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Absence or presence of fish oil</intervention_name>
    <description>Oral dose of saturated fat with or without fish oil and a heparin infusion</description>
    <arm_group_label>SFA</arm_group_label>
    <arm_group_label>SFA + LC n-3 PUFA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy

          -  Either homozygous for eNOS Glu298 (wildtype)or eNOS Asp298 (variant)

        Exclusion Criteria:

          -  Smokers

          -  Raised fasting blood lipids

          -  Taking excessive fish oil supplements (&gt;1g EPA/DHA per day)

          -  Taking medication known to influence blood lipids, blood pressure or blood clotting
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christine M Williams</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Reading</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Reading</name>
      <address>
        <city>Reading</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 6, 2011</study_first_submitted>
  <study_first_submitted_qc>May 9, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 10, 2011</study_first_posted>
  <last_update_submitted>May 9, 2011</last_update_submitted>
  <last_update_submitted_qc>May 9, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 10, 2011</last_update_posted>
  <responsible_party>
    <name_title>Professor Christine Williams</name_title>
    <organization>University of Reading</organization>
  </responsible_party>
  <keyword>Endothelial function</keyword>
  <keyword>Non-esterified fatty acids</keyword>
  <keyword>Insulin sensitivity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heparin</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

